MS Pharma Bags Formycon’s Eylea Biosimilar Rights In MENA
Regional Submissions For Aflibercept Planned At Earliest Opportunity
With an already established network, Formycon’s aflibercept biosimilar licensee Klinge follows in the same footsteps by picking MS Pharma as its MENA region partner.
